196 related articles for article (PubMed ID: 35305725)
1. Immunotherapeutic approaches for HPV-caused cervical cancer.
Fatemi SA; Seifi N; Rasekh S; Amiri S; Moezzi SMI; Bagheri A; Fathi S; Negahdaripour M
Adv Protein Chem Struct Biol; 2022; 129():51-90. PubMed ID: 35305725
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research.
Lee SJ; Yang A; Wu TC; Hung CF
J Gynecol Oncol; 2016 Sep; 27(5):e51. PubMed ID: 27329199
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic human papillomavirus vaccines: current clinical trials and future directions.
Hung CF; Ma B; Monie A; Tsen SW; Wu TC
Expert Opin Biol Ther; 2008 Apr; 8(4):421-39. PubMed ID: 18352847
[TBL] [Abstract][Full Text] [Related]
4. Molecular Approaches Target to Immunotherapy for HPV-Associated Cancers.
Zhang L; Zhou F; Zhao KN
Curr Cancer Drug Targets; 2017; 17(6):512-521. PubMed ID: 27993116
[TBL] [Abstract][Full Text] [Related]
5. Current status and future prospects for human papillomavirus vaccines.
Kim HJ; Kim HJ
Arch Pharm Res; 2017 Sep; 40(9):1050-1063. PubMed ID: 28875439
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines and adolescents.
Kahn JA; Bernstein DI
Curr Opin Obstet Gynecol; 2005 Oct; 17(5):476-82. PubMed ID: 16141761
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus vaccines for cervical cancer.
Murakami M; Gurski KJ; Steller MA
J Immunother; 1999 May; 22(3):212-8. PubMed ID: 10335480
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for HPV Malignancies.
Lee MY; Allen CT
Semin Radiat Oncol; 2021 Oct; 31(4):361-370. PubMed ID: 34455991
[TBL] [Abstract][Full Text] [Related]
9. Vaccination Strategies for the Control and Treatment of HPV Infection and HPV-Associated Cancer.
Farmer E; Cheng MA; Hung CF; Wu TC
Recent Results Cancer Res; 2021; 217():157-195. PubMed ID: 33200366
[TBL] [Abstract][Full Text] [Related]
10. Indications and efficacy of the human papillomavirus vaccine.
Hakim AA; Lin PS; Wilczynski S; Nguyen K; Lynes B; Wakabayashi MT
Curr Treat Options Oncol; 2007 Dec; 8(6):393-401. PubMed ID: 18172770
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenesis Associated with Human Papillomavirus Infection. Mechanisms and Potential for Immunotherapy.
Vonsky M; Shabaeva M; Runov A; Lebedeva N; Chowdhury S; Palefsky JM; Isaguliants M
Biochemistry (Mosc); 2019 Jul; 84(7):782-799. PubMed ID: 31509729
[TBL] [Abstract][Full Text] [Related]
12. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
13. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
Mahdavi A; Monk BJ
Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccine: widening the scope for cancer prevention.
No JH; Kim MK; Jeon YT; Kim YB; Song YS
Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus vaccine against cervical cancer: Opportunity and challenge.
Wang R; Pan W; Jin L; Huang W; Li Y; Wu D; Gao C; Ma D; Liao S
Cancer Lett; 2020 Feb; 471():88-102. PubMed ID: 31812696
[TBL] [Abstract][Full Text] [Related]
16. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccines for the treatment of cervical cancer.
Sin JI
Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus (HPV): unawareness of the causal role of HPV infection in cervical cancer, HPV vaccine availability, and HPV vaccine uptake among female schoolteachers in a Middle Eastern country.
Rezqalla J; Alshatti M; Ibraheem A; Omar D; Houda AF; AlHaqqan S; AlGhurair S; Akhtar S
J Infect Public Health; 2021 May; 14(5):661-667. PubMed ID: 33857726
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
[TBL] [Abstract][Full Text] [Related]
20. Physiopathology and effectiveness of therapeutic vaccines against human papillomavirus.
Ayesha N; Aboulaghras S; Jahangeer M; Riasat A; Ramzan R; Fatima R; Akram M; Balahbib A; Bouyahya A; Sepiashvili E; Zengin G; Shariati MA
Environ Sci Pollut Res Int; 2021 Sep; 28(35):47752-47772. PubMed ID: 34291408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
